Loading companies…
ET
Estrigenix Therapeutics
United States · Biotech · Enterprise software
Developing selective estrogen receptor-beta therapeutics for women's health and neurodegenerative diseases
Funding history
1 round · 1 with disclosed amounts| Announced | Round | Amount | Investors |
|---|---|---|---|
| Seed | $2M | Talents Fund I — Role not disclosed |
Investors
Talents Fund ISeedCoverage
Jul 21, 2026Estrigenix Therapeutics · SeedSimilar companies
AAligatorAI media intelligence for PR and marketing teams to monitor brand coverage, understand audience and competitor sentiment, and spot reputational risks across channels and languages.$1.2M · Seed
AnaCardioAnaCardio is a clinical-stage biopharmaceutical company developing medicines intended to improve heart muscle function in people with heart failure.€62.5M · Series B
AventixAventix builds sensor-based analytical instruments for laboratories. Its first product, Scarlett 01, measures liquid volumes across microplate wells without touching the sample, helping R&D teams check dispensing quality and catch volume variation before it affects assay results.€1.2M · Pre-seed